Ian R. Poxton - Concepedia

Author

Ian R. Poxton

Also Known As

H. Pituch, I POXTON, I Poxton, I R Poxton, I. Poxton, I. R. POXTON, I. R. Poxton, I. R.- Poxton, I.R Poxton, I.R. Poxton

221

Publications

8.2K

Citations

H-Index

117

Concepts

All Affiliations

University of Edinburgh Edinburgh College Scottish National Blood Transfusion Service Moredun Research Institute University Hospital of Wales

About

Ian R. Poxton is an author at University of Edinburgh specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	57	3.3K
2	Health Sciences	14	17	662
3	Natural Sciences	7	7	209
4	Education	5	5	136
5	Engineering	1	1	11

Ian R. Poxton

113

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Bezlotoxumab for Prevention of Recurrent <i>Clostridium difficile</i> Infection Mark H. Wilcox, Dale N. Gerding, Ian R. Poxton, New England Journal of Medicine	2017	832
Extensive DNA Inversions in the <i>B. fragilis</i> Genome Control Variable Gene Expression Ana Cerdeño-Tárraga, Sheila Patrick, Lisa Crossman, Science GeneticsBacteriologyGenomic MechanismMolecular BiologyEscherichia Coli	2005	302
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates Frédéric Barbut, Paola Mastrantonio, Michel Delmée, Clinical Microbiology and Infection Clostridium Difficile InfectionsAntimicrobial StewardshipHealthcare-associated InfectionGenotypic CharacterisationMicrobiology	2007	294
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008 Ed J. Kuijper, Frédéric Barbut, J S Brazier, Eurosurveillance	2008	285
A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides Franco E. Di Padova, Helmut Brade, G R Barclay, Infection and Immunity ImmunologyEscherichia ColiAntigen ProcessingSalmonella LipopolysaccharidesCross-protective Monoclonal Antibody	1993	193
Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling Clett Erridge, John Stewart, Ian R. Poxton The Journal of Experimental Medicine Innate Immune SystemImmunologyHuman Tlr4 GeneEscherichia ColiMonocytes Heterozygous	2003	191
Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2 Clett Erridge, Alison C. Pridmore, Adrián Eley, Journal of Medical Microbiology Tlr2-signalling LpsInnate Immune SystemImmunologyBacteriophageBacteroides Fragilis	2004	183
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe Ed J. Kuijper, B. Coignard, J S Brazier, Eurosurveillance Recent OutbreaksNorth AmericaMedicineType 027Pathogenesis	2007	161
A European survey of diagnostic methods and testing protocols for Clostridium difficile Frédéric Barbut, Michel Delmée, J S Brazier, Clinical Microbiology and Infection Medical DiagnosticsAntimicrobial SusceptibilityPathogen DetectionClostridium DifficileDiagnostic Test	2003	123
International Clostridium difficile animal strain collection and large diversity of animal associated strains Sandra Janežič, Valerija Zidarič, Bart Pardon, BMC Microbiology	2014	118

Page 1